Intimation of Earnings Conference Call
HealthCare Global Enterprises Ltd has informed BSE that an Earnings Conference Call has been scheduled to discuss on the Companys Financial Results (Limited Review) for the quarter and nine months ended December 31, 2016 on February 08, 2017 at 5.00 p.m. (IST). Issue of additional shares by Subsidiary Company
HealthCare Global Enterprises Ltd has informed BSE that the Company has made investment in Equity Share Capital of HCG Regency Oncology Healthcare Private Limited, the Subsidiary Company, to the extent of Rs. 49,99,995 by subscribing to additional 4,54,545 Equity shares of Rs. 10 each at a premium of Re. 1 per share. The Company continues to hold 51% of shareholding in the said subsidiary Company. Board Meeting on Feb 08, 2017
HealthCare Global Enterprises Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 08, 2017, inter alia, to:1. Consider, approve and take on record the Unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter and nine months ended on December 31, 2016.2. Approve issue and allot equity shares of the Company under Employee Stock Option Scheme of the Company. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
HealthCare Global Enterprises Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended December 31, 2016
HealthCare Global Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Closure of Trading Window
HealthCare Global Enterprises Ltd has informed BSE that in pursuance of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Insider Trading Policy and Code of Practices/ Procedures for Fair Disclosure of Unpublished Price Sensitive Information adopted by Healthcare Global Enterprises Limited (the Company), the Company hereby announce that the closure of trading window for purchase or sale of Companys shares would start from January... Issue of additional shares by Subsidiary company
HealthCare Global Enterprises Ltd has informed BSE that the Company has made investment in Equity Share Capital of HCG Regency Oncology Healthcare Private Limited, the Subsidiary Company, to the extent of Rs. 49,99,995 by subscribing to additional 4,54,545 Equity shares of Rs. 10 each at a premium of Re. 1 per share. The Company continues to hold 51% of shareholding in the said subsidiary company. Intimation of Schedule of Investor Meetings
HealthCare Global Enterprises Ltd has informed BSE regarding "Intimation of Schedule of Investor Meetings". Intimation of Schedule of Investor Meetings
HealthCare Global Enterprises Ltd has informed BSE regarding "Intimation of Schedule of Investor Meetings". Intimation of Schedule of Investor Meetings
HealthCare Global Enterprises Ltd has informed BSE regarding "Intimation of Schedule of Investor Meetings".